Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

March 29, 2021

Video: Sharing a Journey with a Newly Diagnosed Person with MS, during COVID-19

  • MS Educational Programs
    /
  • Multiple Sclerosis
    /
MS Views Now – with Patient Leader Lina Light Keep in-touch and up-to-date with MS News:  Click HERE to Subscribe…
MS Educational Programs

March 25, 2021

Emerald Health Pharmaceuticals Starts Activities for Initiation of Phase 2 Clinical Study in Multiple Sclerosis

  • MS Research Study and Reports
    /
March 8, 2021 HP-101, a novel product candidate with a unique multi-modal mechanism of action, has demonstrated disease-modifying potential in…
MS Research Study and Reports

March 23, 2021

VIDEO: The IMPACT of COVID-19 and COVID Vaccine on the MS Community

  • #COVID-19
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis Videos
    /
event date: March 3, 2021 Presented by Emily S. Riser, MD Medical Director of the Tanner MS Center, Birmingham, AL.…
#COVID-19

March 23, 2021

How Multiple Sclerosis Affects the Brain

  • Multiple Sclerosis
    /
Multiple sclerosis (MS) is caused by immune cells attacking  the central nervous system (CNS) –the brain and spinal cord.  MS is…
Multiple Sclerosis

March 23, 2021

New study shines light on causes of dementia

  • Misc. MS Related
    /
  • Misc. Research Reports
    /
  • Other Neuro Conditions
    /
  • Alzheimer’s and Dementia
    /
By JULIAN SHEA in London | China Daily Global | Updated: 2021-03-15 04:55A new study led by the University of…
Misc. MS Related

March 22, 2021

FDA Approves Ponvory (ponesimod) For Adults With Relapsing Forms of MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
 FDA APPROVED       Ponesimod Medication Description Description Ponesimod, sold under the brand name Ponvory, is a medication for…
MS Drug Therapies

March 22, 2021

Participation is needed in Research Studies

  • Clinical Trials
    /
  • National MS Society Related
    /
Information showing below is provided by The National MS Society NOTE: The COVID-19 pandemic may affect the status of the…
Clinical Trials

March 18, 2021

Understanding Effects of Diagnosis Disclosure in MS: Anne Kever, PhD

  • An MS Patients Story
    /
  • Multiple Sclerosis
    /
March 15, 2021 Anne Kever, PhD The postdoctoral researcher at Columbia University discussed her abstract from ACTRIMS Forum 2021 on…
An MS Patients Story

March 17, 2021

What’s the Difference Between Neuromyelitis Optica and MS?

  • Multiple Sclerosis (MS) Symptoms
    /
  • NMO (NMOSD/Devics)
    /
Two nerve conditions Multiple sclerosis (MS) is a disease in which the body’s immune system attacks myelin, the outside layer of nerve cells.…
Multiple Sclerosis (MS) Symptoms

March 16, 2021

BTK blockers make headway in multiple sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
By targeting both arms of the immune system, not just B cells, brain-penetrant inhibitors of Bruton’s tyrosine kinase could improve…
MS Research Study and Reports

Categories

Latest Blog Posts